Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier
Crossref DOI link: https://doi.org/10.1038/aps.2017.44
Published Online: 2017-05-08
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Jing-jing
Chen, Yi-chao
Huang, Yi-xian
Zhao, Wen-chen
Liu, Yan-hua
Venkataramanan, Raman
Lu, Bin-feng
Li, Song
Text and Data Mining valid from 2017-05-08
Article History
Received: 2 December 2016
Accepted: 12 February 2017
First Online: 8 May 2017